Tapewire

Nasdaq · USD

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Export transactions ↓
Tapewire entity
5650
SEC CIK
0001299130
Parsed reports
244

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202606
Mar 202603
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 25, 2022 Filed May 27, 2022 23:35 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000087 · certent-form4.xml · derivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 19:31 UTC
Shapiro LucyDirector
GrantStock option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000085 · certent-form4.xml · derivative · entry 1

Shapiro Lucy · CIK 0001435944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 23:24 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000079 · certent-form4.xml · derivative · entry 1

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 23:38 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000089 · certent-form4.xml · derivative · entry 1

MOHR MARSHALL · CIK 0001252986 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 23:29 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000083 · certent-form4.xml · derivative · entry 1

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 23:27 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000081 · certent-form4.xml · derivative · entry 1

MILLIGAN JOHN F · CIK 0001191589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 23:20 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000077 · certent-form4.xml · derivative · entry 1

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 25, 2022 Filed May 27, 2022 23:15 UTC GrantStock Option (right to buy) · Derivative 63,015 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001299130-22-000075 · certent-form4.xml · derivative · entry 1

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,015

Underlying: Common Stock · 63,015 shares

Expires 2032-05-25

F1 · derivative.exercise_date: The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.

Read SEC document
May 18, 2022 Filed May 20, 2022 15:31 UTC
Farmer MicheleSee Remarks
SaleCommon Stock 3,573 $5.55 $19,819.43
Disclosure

SEC source: 0001299130-22-000055 · certent-form4.xml · nonDerivative · entry 1

Farmer Michele · CIK 0001860876 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,354

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $5.547 to $5.555 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F3 · balance_after: Includes 1,427 shares purchased on March 1, 2022 under the Company's 2010 Employee Stock Purchase Plan.

Read SEC document
March 17, 2022 Filed Apr 14, 2022 01:26 UTC OtherCommon Stock 1,268 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-014756 · doc4.xml · nonDerivative · entry 4

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,336

F5 · kind: Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners.

F5 · price: Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners.

F6 · ownership.direct: Shares are directly held by William Ericson, and were received pursuant to the in-kind distribution without consideration by MDV VII Leaders' Fund, L.P. to its partners.

Read SEC document
March 17, 2022 Filed Apr 14, 2022 01:26 UTC OtherCommon Stock 4,848,397 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-014756 · doc4.xml · nonDerivative · entry 3

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · MDV VII LP, nom for MDV VII LP, MDV VII Leaders' Fund LP, MDV ENF VII (A) LP, and MDV ENF VII (B) LP

Disclosed balance after: 0

F5 · kind: Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners.

F5 · price: Distribution in kind from MDV VII Leaders' Fund, L.P., MDV VII, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., without consideration to their partners.

F3 · ownership.nature: Seventh MDV Partners, L.L.C. is the general partner of (i) MDV VII, L.P., as nominee for MDV VII, L.P., MDV VII Leaders' Fund, L.P., MDV ENF VII(A), L.P, and MDV ENF VII(B), L.P., (ii) MDV VII, L.P., (iii) MDV ENF VII(A), L.P., (iv) MDV ENF VII(B), L.P. and (v) MDV VII Leaders' Fund, L.P. (the "MDV VII Funds") and has sole voting and investment power over the shares. William Ericson is a Managing director with Mohr Davidow Ventures, but is not a Managing Member of Seventh MDV Partners, LLC, however he may be deemed to indirectly beneficially own the shares affiliated with the MDV VII Funds. Mr. Ericson disclaims beneficial ownership of the shares held by the MDV VII Funds except to the extent of any pecuniary interest therein.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:30 UTC
Farmer MicheleSee Remarks
GrantStock Option (right to buy) · Derivative 44,800 $0.00 Strike: $11.70 $0.00
Disclosure

SEC source: 0001299130-22-000041 · certent-form4.xml · derivative · entry 2

Farmer Michele · CIK 0001860876 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,800

Underlying: Common Stock · 44,800 shares

Expires 2032-03-02

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 19:30 UTC
Farmer MicheleSee Remarks
GrantCommon Stock 22,500 $0.00 $0.00
Disclosure

SEC source: 0001299130-22-000041 · certent-form4.xml · nonDerivative · entry 1

Farmer Michele · CIK 0001860876 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:23 UTC
Van Oene MarkSee Remarks
GrantStock Option (right to buy) · Derivative 433,200 $0.00 Strike: $11.70 $0.00
Disclosure

SEC source: 0001299130-22-000035 · certent-form4.xml · derivative · entry 2

Van Oene Mark · CIK 0001707477 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 433,200

Underlying: Common Stock · 433,200 shares

Expires 2032-03-02

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:23 UTC
Van Oene MarkSee Remarks
GrantCommon Stock 72,500 $0.00 $0.00
Disclosure

SEC source: 0001299130-22-000035 · certent-form4.xml · nonDerivative · entry 1

Van Oene Mark · CIK 0001707477 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 366,020

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:27 UTC
Kim Susan G.See Remarks
GrantStock Option (right to buy) · Derivative 239,000 $0.00 Strike: $11.70 $0.00
Disclosure

SEC source: 0001299130-22-000039 · certent-form4.xml · derivative · entry 2

Kim Susan G. · CIK 0001825421 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,000

Underlying: Common Stock · 239,000 shares

Expires 2032-03-02

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:27 UTC
Kim Susan G.See Remarks
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001299130-22-000039 · certent-form4.xml · nonDerivative · entry 1

Kim Susan G. · CIK 0001825421 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,966

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:26 UTC
Fromen PeterSee Remarks
GrantStock Option (right to buy) · Derivative 298,700 $0.00 Strike: $11.70 $0.00
Disclosure

SEC source: 0001299130-22-000037 · certent-form4.xml · derivative · entry 2

Fromen Peter · CIK 0001838928 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 298,700

Underlying: Common Stock · 298,700 shares

Expires 2032-03-02

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:26 UTC
Fromen PeterSee Remarks
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001299130-22-000037 · certent-form4.xml · nonDerivative · entry 1

Fromen Peter · CIK 0001838928 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,280

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:21 UTC GrantStock Option (right to buy) · Derivative 642,300 $0.00 Strike: $11.70 $0.00
Disclosure

SEC source: 0001299130-22-000033 · certent-form4.xml · derivative · entry 2

HENRY CHRISTIAN O · CIK 0001263805 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 642,300

Underlying: Common Stock · 642,300 shares

Expires 2032-03-02

F2 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
March 02, 2022 Filed Mar 5, 2022 00:21 UTC GrantCommon Stock 107,500 $0.00 $0.00
Disclosure

SEC source: 0001299130-22-000033 · certent-form4.xml · nonDerivative · entry 1

HENRY CHRISTIAN O · CIK 0001263805 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 779,858

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 2 of each of 2023, 2024, 2025, and 2026, subject to the Reporting Person's continued status as a service provider through the applicable vesting dates.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:47 UTC
Kim Susan G.Chief Financial Officer
SaleCommon Stock 1,062 $11.06 $11,745.72
Disclosure

SEC source: 0001299130-22-000026 · certent-form4.xml · nonDerivative · entry 1

Kim Susan G. · CIK 0001825421 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,966

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $11.060 to $11.065 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 21:44 UTC
HENRY CHRISTIAN OPresident & CEO
SaleCommons Stock 2,122 $11.09 $23,532.98
Disclosure

SEC source: 0001299130-22-000024 · certent-form4.xml · nonDerivative · entry 1

HENRY CHRISTIAN O · CIK 0001263805 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 672,358

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $11.08 to $11.10 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
February 16, 2022 Filed Feb 18, 2022 01:11 UTC SaleCommon Stock 3,280 $11.50 $37,720.00
Disclosure

SEC source: 0001299130-22-000022 · certent-form4.xml · nonDerivative · entry 1

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,595

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $11.50 to $11.505 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 23:54 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.57 $0.00
Disclosure

SEC source: 0001562762-22-000005 · primary_doc.xml · derivative · entry 2

MOHR MARSHALL · CIK 0001252986 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-01-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
January 14, 2022 Filed Jan 19, 2022 23:54 UTC Exercise / conversionCommon Stock 25,000 $3.57 $89,250.00
Disclosure

SEC source: 0001562762-22-000005 · primary_doc.xml · nonDerivative · entry 1

MOHR MARSHALL · CIK 0001252986 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 11, 2022 Filed Jan 13, 2022 23:15 UTC
Van Oene MarkChief Operating Officer
SaleCommon Stock 41,480 $14.23 $590,260.40
Disclosure

SEC source: 0001299130-22-000012 · certent-form4.xml · nonDerivative · entry 1

Van Oene Mark · CIK 0001707477 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,520

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $14.05 to $14.42 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
January 11, 2022 Filed Jan 13, 2022 23:13 UTC
Fromen PeterChief Commercial Officer
SaleCommon Stock 19,720 $14.30 $281,996.00
Disclosure

SEC source: 0001299130-22-000010 · certent-form4.xml · nonDerivative · entry 1

Fromen Peter · CIK 0001838928 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,280

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $14.30 to $14.34 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
September 29, 2021 Filed Oct 1, 2021 21:31 UTC
Kim Susan G.Chief Financial Officer
SaleCommon Stock 20,272 $25.75 $522,004.00
Disclosure

SEC source: 0001299130-21-000210 · certent-form4.xml · nonDerivative · entry 1

Kim Susan G. · CIK 0001825421 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,028

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $25.61 to $25.80 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
September 16, 2021 Filed Sep 17, 2021 20:53 UTC
HENRY CHRISTIAN OPresident & CEO
SaleCommon Stock 90,520 $26.91 $2,435,893.20
Disclosure

SEC source: 0001299130-21-000198 · certent-form4.xml · nonDerivative · entry 1

HENRY CHRISTIAN O · CIK 0001263805 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 674,480

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
September 16, 2021 Filed Sep 21, 2021 01:40 UTC Amendment
HENRY CHRISTIAN OPresident & CEO
SaleCommon Stock 90,520 $26.91 $2,435,893.20
Disclosure

SEC source: 0001299130-21-000204 · certent-form4a.xml · nonDerivative · entry 1

HENRY CHRISTIAN O · CIK 0001263805 · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 674,480

F1 · shares: Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $26.72 to $27.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4/A.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:46 UTC GrantStock Option (right to buy) · Derivative 28,992 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000186 · certent-form4.xml · derivative · entry 1

Valantine Hannah · CIK 0001855608 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,992

Underlying: Common Stock · 28,992 shares

Expires 2031-06-16

F1 · derivative.exercise_date: Dr. Valantine was elected to the Board of Directors on June 16, 2021. One-third of the shares subject to the option will vest on the one year anniversary of Dr. Valantine joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as her initial start date, provided she continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 21, 2021 21:24 UTC
Shapiro LucyDirector
GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000182 · certent-form4.xml · derivative · entry 1

Shapiro Lucy · CIK 0001435944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:21 UTC GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000180 · certent-form4.xml · derivative · entry 1

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:20 UTC GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000178 · certent-form4.xml · derivative · entry 1

MOHR MARSHALL · CIK 0001252986 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:18 UTC GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000176 · certent-form4.xml · derivative · entry 1

MILLIGAN JOHN F · CIK 0001191589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:17 UTC GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000174 · certent-form4.xml · derivative · entry 1

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:15 UTC GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000172 · certent-form4.xml · derivative · entry 1

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
June 16, 2021 Filed Jun 22, 2021 01:14 UTC GrantStock Option (right to buy) · Derivative 12,885 $0.00 Strike: $27.90 $0.00
Disclosure

SEC source: 0001299130-21-000170 · certent-form4.xml · derivative · entry 1

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,885

Underlying: Common Stock · 12,885 shares

Expires 2031-06-16

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, or, if earlier, on the date of the next annual meeting of stockholders, provided the Reporting Person continues to serve as a director through each vesting date.

Read SEC document
May 25, 2021 Filed May 27, 2021 00:50 UTC Exercise / conversionStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $1.83 $0.00
Disclosure

SEC source: 0001299130-21-000152 · certent-form4.xml · derivative · entry 6

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2022-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
May 25, 2021 Filed May 27, 2021 00:50 UTC Exercise / conversionStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $10.58 $0.00
Disclosure

SEC source: 0001299130-21-000152 · certent-form4.xml · derivative · entry 5

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2021-06-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
May 25, 2021 Filed May 27, 2021 00:50 UTC SaleCommon Stock 900 $26.42 $23,777.10
Disclosure

SEC source: 0001299130-21-000152 · certent-form4.xml · nonDerivative · entry 4

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2021.

F3 · price: This sale price represents the weighted average sale price of the shares sold ranging from $26.37 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
May 25, 2021 Filed May 27, 2021 00:50 UTC SaleCommon Stock 36,600 $25.88 $947,281.20
Disclosure

SEC source: 0001299130-21-000152 · certent-form4.xml · nonDerivative · entry 3

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 900

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2021.

F2 · price: This sale price represents the weighted average sale price of the shares sold ranging from $25.37 to $26.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
May 25, 2021 Filed May 27, 2021 00:50 UTC Exercise / conversionCommon Stock 25,000 $1.83 $45,750.00
Disclosure

SEC source: 0001299130-21-000152 · certent-form4.xml · nonDerivative · entry 2

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 25, 2021 Filed May 27, 2021 00:50 UTC Exercise / conversionCommon Stock 12,500 $10.58 $132,250.00
Disclosure

SEC source: 0001299130-21-000152 · certent-form4.xml · nonDerivative · entry 1

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 17, 2021 Filed May 19, 2021 16:25 UTC
Farmer MicheleChief Accounting Officer
GrantStock Option (right to buy) · Derivative 80,000 $0.00 Strike: $23.39 $0.00
Disclosure

SEC source: 0001209191-21-034007 · doc4.xml · derivative · entry 2

Farmer Michele · CIK 0001860876 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2031-05-17

F2 · derivative.exercise_date: 1/4 of the shares subject to the option will vest on the one year anniversary of the date of grant, and the balance of shares will vest monthly thereafter over the next three years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
May 17, 2021 Filed May 19, 2021 16:25 UTC
Farmer MicheleChief Accounting Officer
GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-034007 · doc4.xml · nonDerivative · entry 1

Farmer Michele · CIK 0001860876 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · shares: Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on May 17 of each of 2022, 2023, 2024, and 2025, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 45,134 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001299130-21-000107 · certent-form4.xml · derivative · entry 10

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 45,134 shares

Expires 2027-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 79,363 $0.00 Strike: $7.87 $0.00
Disclosure

SEC source: 0001299130-21-000107 · certent-form4.xml · derivative · entry 9

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 79,363 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
February 26, 2021 Filed Mar 3, 2021 01:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 109,749 $0.00 Strike: $5.72 $0.00
Disclosure

SEC source: 0001299130-21-000107 · certent-form4.xml · derivative · entry 8

Hunkapiller Michael · CIK 0001317102 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 109,749 shares

Expires 2025-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.